chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Yesterday morning I got a flu shot. My first time getting one. By late afternoon I felt like I was getting ill. By 6pm I felt awful. I went to lay down, before I could make it into bed I got the "chills" and started shaking so badly it sent my glasses flying off my face  halfway across the room. I got into bed to try to warm up, still shivering and shaking more like convulsions. It became hard to breathe, I was short of breath. When my wife came into the room she tried to get me to go to the hospital. I was dazed and sort of semi-conscious. I kept saying "I'll be ok, I can't get up now." She called 911 and paramedics arrived. By that time I was not aware of what was happening. They "hooked me up" to their equipment and ran me through the tests. I had a fever and my blood pressure was up. It did not seem life-threatening, so I convinced them to leave me in bed (I HATE hospitals) and if anythying happened or got worse we'd go straight there (1/2mi. away.) Woke up at 2PM today, still feeling awful, but on the mend. Coincidence? I don't think so. Anyway that is my experience...
Information has been received from a medical assistant referring to an unspecified patient. Information about concomitant medications, pertinent medical history and drug reactions/allergies was not reported. On an unknown date, unspecified patients were inadvertently administered doses of VARIVAX (lot#: R018933, Expiration Date: 02-JUL-2020) and PROQUAD (lot#: R022564, Expiration Date: 04-FEB-2020; lot#: R022573, Expiration Date: 04-FEB-2020) for prophylaxis. All lots of VARIVAX and PROQUAD were reconstituted with properly stored sterile diluent. The administered doses experienced a temperature excursion at 32.9F for 13 hours. Previous excursions were reported as from 15F to 46F (16F) for 1 hour. The temperature excursions were detected by a data logger (Product storage error). Other suspect therapies included PEDVAXHIB (lot#: R014262, Expiration Date: 26-MAR-2021; lot#:R013572, expiration date: 21-Mar-2021). The administered doses experienced a temperature excursion at 48.4F for 15 minutes. Previous excursions were reported as total time and highest temperature above 47F/9 degree for 9 hours. No adverse effect reported. This is a non-valid case due to not have identifiable patient.
"I was at work on 10/29/09 - when my stomach started to hurt. After a short while it felt better."
Patient received a vaccine that was one-hour outside of the 6-hour reconstitution window. Vial was reconstituted and diluted at 9:30 am on 10/16/21 and was to expire 6 hours post-reconstitution at 3:30 pm. Patient arrived at 4:30 pm to receive 2nd-dose and received vaccine one-hour after expiration window. Per Pfizer guideline, patient is to be revaccinated with 2nd dose. Patient has been contacted and is coming to receive another 2nd-dose on Monday, October 18, 2021
Itchy eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE PRURITUS (Itchy eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced EYE PRURITUS (Itchy eyes). At the time of the report, EYE PRURITUS (Itchy eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Patient received first dose from her work and missed her appt for her second dose. She called  and requested to get her second dose from us and reported she received moderna. We scheduled her atleast 4 weeks from her first dose. After she received the second dose and we were charting the dose, we noticed her first vaccine was pfizer.
Conception on 10/15/21  Miscarriage at 10 weeks pregnant   Baby stop developing at 8 weeks - 12/10/21  2nd Covid vaccine administered on 11/30/21  Time from vaccination until development stop - 10 days
A few hours after receiving the booster vaccine, I experienced extreme vertigo and almost blacked out at the same time. This happened twice the evening of the vaccine. I continued to have extreme intermittent vertigo for months and almost blacked out on Wednesday, 10/6 while sitting in class. I never blacked out, but felt dizzy and saw black spots at the edge of my vision. The last incidence of almost blacking out occurred on 10/6, but I continued to experience episodes of extreme intermittent vertigo 3-5 times a day until the end of November. Since 10/2, I have been off balance and mildly dizzy all the time. I continue to be off balance and vestibular therapy has not helped.
Information has been received regarding a case in litigation from a lawyer and a 61-year old patient (gender unknown) referring to himself or herself. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 01-NOV-2015, the patient was administered the ZOSTAVAX by a physician at a physician's office (lot number, dosage and route of administration not provided). On or about 02-NOV-2015, the patient was treated by a physician at the physician's office (same physician who administered vaccine to patient) for the following injury resulting from the ZOSTAVAX use: Shingles. The patient claims damages including: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the shingles was unknown. Additional information has been requested.
Initial and follow-up information has been received from a registered nurse concerning a 22 year old white female with a history of mild asthma who on 28-DEC-2007 was vaccinated with a second dose of Gardasil (lot# 658563/1063U) IM in the left deltoid.  There was no concomitant medication.  On 30-DEC-2007 the patient noted itching at the site.  On 02-JAN-2008, the patient noted pain with movement of the left arm and swelling.  The patient called the office on 03-JAN-2008.  The patient was seen the same day and there was no redness.  The patient had a 2-3 cm subcutaneous mass at the injection site.  Medical attention was sought.  The patient was treated with diphenhydramine hcl (BENADRYL) and warm soaks.  No further information was provided.  The patient recovered on 14-JAN-2008.  It was recommended that there was no third injection to be administered.  Additional information is not expected.
The worst menstrual migraine of my life, the first period after my second vaccination for covid. I have had menstrual migraines (around first or last day of period) almost every month for a long time, with my first migraine ever appearing at age 25. Sometimes I vomit. For this menstrual migraine, I lost count of how many times I vomited over the 24 hour migraine. I vomited every time I moved so often that my stomach hurt badly from the vomiting. It was an order of magnitude pain and nausea with migraine greater than I have ever experienced in my life and I am used to monthly migraines where if the medicine does not work I have to lay in bed 24 hours in great pain. My menstruation was also longer, nearly 2 weeks instead of 1.  The migraines gradually lessened with each period over 3 months, but they were the worst I have ever experienced as a group. I know already that the contraceptive pill is contraindicated for me because of my migraines and the risk of brain hemorrhage. So what is the connection between the vaccine and menstrual changes INCLUDING menstrual migraine. Are those of us with menstrual migraine at more risk for e.g. blood clots or blood vessel disruption? The menstruation disturbances and vaccination connection needs to be explained.
Pulmonary Embolisms: 2 weeks after receiving the 4th shot, I was experiencing shortness of breath and heart arrythmia, and tightness in my chest. I went into the hospital and was diagnosed with Pulmonary Embolisms in all 4 lobes of my lungs, as well as NSTEMI because of them. I had a recent history of arrythmia in the recent years, possibly after starting the vaccines. I had an echocardigram a few months previous because of this, and it was normal.
ACUTE RESPIRATORY FAILURE 8/23/2022 -- RECURRENCE OF SAME SYMPTOMS
Same day post vax, the pt spiked a temperature of 103. Complained of headache for a few days and rash started 1-2 days after receipt. Fine, reddish rash with 8-10 vesicular looking lesions 2 days post vax. Then 3 days later, 3 more pimple-vesicular like lesions.
Rash at injection site, pt said she is going to see her doctor today 6/28/12.
PATIENT WAS GIVEN  .25 ML FOR HER FIRST DOSE.  SHE STAYED AT CLINIC FOR 30 MINUTES DUE TOPREEXISTING CONDITIONS AND HAD  NO ADVERSE REACTION.
Information has been received from a 19 years old female patient referring to herself, who had drug allergies to sulfur, ibuprofen and BACTRIM. The patient had no pertinent medical history. Concomitant therapies included VIORELE, and DEXILANT. On an unknown date, the patient started therapy with 3 dose series GARDASIL 9 injection (dose, frequency and route were unknown). On an unknown date in June 2012, the patient was administered her final dose of GARDASIL 9. In late September 2012, the patient was diagnosed with Poly Cystic Ovary Syndrome (PCOS) by a most recently retired physician. The patient began experiencing hair growth above the upper lip area, and she also began having changes in her menstrual cycle (periods became very light and also less frequent). The patient sought for medical attention and reported to a physician who was treating her for PCOS. On an unknown date in the 2013, the patient began having an acid reflux issue. The outcome of the events PCOS and acid reflux issue was unknown. The causality assessment between the events and GARDASIL 9 was not reported. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to "unspecified anonymous patients. Medical history and drug reactions were not reported. In 2013 the patients were vaccinated with improperly stored PNEUMOVAX23 lot number J006082, expiration date 12-APR-2014. Route and concentration were not reported. No concomitant therapies were reported. Since 18-AUG-2013 to 21-AUG-2013 (3 days) PNEUMOVAX23 was improperly storage it was exposed to as low as 22F going in and out of range at least seven times. The reporter was unsure if any of the PNEUMOVAX23 was administered within the following dates that the temperature excursion occurred. Six vials of PNEUMOVAX23 were involved.  No adverse events were reported. Additional information has been requested.
This spontaneous report was received from an unspecified healthcare professional concerning an unspecified number of patients of unknown age and gender. Since an unknown date between September 2012 and November 2012, patients were vaccinated with the doses of improperly stored (exposed for 28 hours at 30 Fahrenheit) GARDASIL (lot number and expiry date reported as 669313/0692AA and 13-AUG-2013 respectively, dose and route unspecified). No concomitant medications were reported. No adverse effects were reported. This is one of the several reports from the same source. Additional information has been requested.
3" red spot around the shor area, warm & tender. Red rash throughout body,mostly in warm areas; arm pits, waist, buttocks, back.  Other than the rash, I feel good, no itching or respirator issues. Do I need to be aware of anything else?
This is a spontaneous report from a contactable physician. A 20 years old female patient of unspecified age, race and gender received the first single dose of TRUMENBA (Lot N77282, Expiry Date 30Jun2017) on 08Jul2016 for immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever after first dose of vaccine on an unspecified date in 2016 with unknown outcome.
17years and 8 months got the first dose of Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17years and 8 months got the first dose of Moderna vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17years and 8 months got the first dose of Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17years and 8 months got the first dose of Moderna vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 08-JUN-2021 contains non-significant information. Reporter declined giving her personal email but said she is happy to speak over the phone to the safety department.
HPV vaccine given at Elementary School clinic. About 10 minutes after HPV adminictered in left deltoid, child began c/o numbness/tingling in the whole arm and hand radiating to that scapula. Complaints worsened for 3 hours. Hand also became visably [but not grossly] swollon. Pulses, perfusion,sensaton, strength were normal in the hand. 200mg ibuprofen was given and we elevated arm. She felt relief but not resolution in 1 hour. The hand was normal 2 hours later. Pain and tingling still present but markedly less. The next morning it was totally resolved per school health aide. We think the hand swelling may be due to her dangling and favoring arm at the time.
Patient began to develop a rash with itching. Vital signs taken all remained with in normal limits. Patient observed and no other symptoms developed and patient went home.
complained of light-headedness about 10 minutes after receiving her injection.  Vital signs taken: 130/80-93 HR and regular, O2 sat=100%.  Encouraged to drink fluids and was given 2 bottles of water, granola bar.  Had lunch earlier today.  After about 10 minutes, started to feel better and left the with her husband who was driving home.  Text received that she arrived home safely and no further sxs noted.
1505 right eye heaviness, BP: 114/61, 02 saturation: 100%, HR:74, pt sent to ED
Within a few hours my eyes, face, arm, and glands under arm were swollen.  Throat felt tight.   Injection site red, swollen, painful and itching    Terrible headache.  Felt ill and exhausted up and including today
This spontaneous report as received from a registered nurse refers to a multiple unspecified patients of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, multiple unspecified patients were vaccinated with GARDASIL (dose, dose number, route, anatomical location, lot number and expiration date were unspecified), after the vaccines were exposed to temperatures from outside of recommended condition. No adverse events were reported. No concomitant therapies were reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I have had 2 shingles outbreaks previous to receiving Shingrix. My outbreaks weren't exactly typical as the rashes were small and in unusual places - I had one outbreak on the sole of my foot. The pain would be intense but manageable before the outbreak, easing off once the blisters surfaced. All told an outbreak would last a week to 10 days.   I had Shingrix about 6 months ago. Several weeks ago I pulled a muscle in my back. My back was seizing up, and the pain was migrating around the front of my torso and into my stomach. My whole left side of my torso was in excruciating pain. I first went to an urgent care clinic and was prescribed muscle relaxers. They did nothing. That night the pain was so bad I went to the emergency room. I was given an IV anti-inflammatory drug - nothing. I was then given an IV opioid, which took the edge off.   I was prescribed opioids, and they helped if I took enough. Then the skin on my stomach started to get that burning/itching feeling and I recognized it as shingles. I had a rash on my left buttocks. I went to my provider and she confirmed my condition. I was prescribed neurontin.   Instead of my normal 7 - 10 day manageable outbreak, this one has lasted 18 days and counting. Not only that, but the pain was at a level I never experienced. I've done a full course of Valtrex, but the shingles remains. The rash has now cleared up, but the skin and stomach pain remain.  In my experience, Shingrix not only didn't prevent an outbreak it actually intensified the symptoms X3.   I have HSV2, if that has any bearing on anything.
Headache, chills, neck pain, eyes hurt and vision was odd, nausea, fever (104.1 Peak), body aches, exhausted. Took ibuprofen every 3 to 4 hours, but it didn't bring the fever all the way down or stop the pain. Had to seek medical care on Thursday. Was prescribed prednisone and medication for nausea. I am still fatigued and vision is still off compared to what it usually is. The fever lasted even with the meds until Sunday off and on. Still not feeling "normal" yet.
fatigue, Short of breath, lung congestion, nasal congestion Narrative: Pt reported he had a sore arm at injection site for 2 weeks. reported had 3 weeks of the following symptoms; fatigue, shortness of breath, nasal congestion, lung congestion. The patient received his 1st vaccine approximately 3 weeks after recovering from Covid-19. Pt states he had Covid-19 in December of 2019.
tc on 28AUG92 stated lt arm had been red since inject on 25AUG92 states hadchills & fever but had not taken temp; red area lt arm approx 5 x 7 per pt also noted swelling lt breast; advised to be seen immed; MD felt was infection given meds;
NOTICED 3.7CM UNIFORMLY RED CIRCLE SHAPED REACTION AT INJECTION SITE, PAINFUL, RAISED. AS IT RESOLVED OVER SEVERAL DAYS IT BECAME FLAT, SAME SIZE, THEN FADED. I HAVE A PHOTO IF DESIRED.
4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration; 4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration) and PRODUCT STORAGE ERROR (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration) and PRODUCT STORAGE ERROR (4 patients received their 3rd doses of the Moderna Covid-19 Vaccine 33 days after the vial was moved to refrigeration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment informations were reported.
I am not feeling well; Caller coughed at the end of the call; I have a temperature of a 102; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I am not feeling well), COUGH (Caller coughed at the end of the call) and PYREXIA (I have a temperature of a 102) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced MALAISE (I am not feeling well), COUGH (Caller coughed at the end of the call) and PYREXIA (I have a temperature of a 102). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MALAISE (I am not feeling well), COUGH (Caller coughed at the end of the call) and PYREXIA (I have a temperature of a 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (abnormal) temperature of a 102.         No concomitant drug details were reported. No treatment details were reported.
Pt received vaccine in right arm on 1/7/21. Pt notes 3 days later a rash appeared on his right shoulder/upper arm area. Multiple rashes appears throughout pts upper body all varying in shape and size. There is one rash on his back that has continued to get bigger, none have seemed to improve. Pt notes that rash does mildly itch. Pt presents to clinic today seeking advise. Recommend pt follow up with PCP and let him know that I would report his information.
Information has been received from a registered nurse referring to a patient of unknown age and gender. On 10-AUG-2015, the patient was inadvertently vaccinated with a dose of (Oka/Merck) VARIVAX (lot # L012038, expiration date 17-APR-2017,d ose and route were unknown) instead of an intended dose of ZOSTAVAX. ZOSTAVAX was not administered. No adverse effect reported. No product confusion reported. This is one of two reports received from the same source. Additional information has been requested.
Pt with tactile fever, spots over chest, back, face, neck, and upper arms. Very itchy. Home care with OTC's to decrease symptoms. When seen 05/03 some scarring over buttocks from chicken pox. No other issues.
No adverse event.  MMR II given IM not SC. Pharmacy guidelines advise MMR to be given SC.
Painful swollen right large toe joint, then moved to ankles, knees, wrists and hands. Moving from one joint to another occurred over 7-10 days.   Continue with hand pain at time of this report (which is 12/4/14).  The pain was disruptive of walking, bending knees and using hands.